Novo Nordisk shares pop 10% on early-stage weight loss drug trial results

A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024.

Tom Little | Reuters

Shares of Novo Nordisk jumped Friday after the Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

The trial showed average weight reduction of 22% in obese and overweight patients after 36 weeks.

Shares were last up 9.5% at 11:02 a.m. London time.

This is a developing story. Please check back for updates.

Source

World

‘Abnormal hatred’ between Putin and Zelenskyy making it hard to reach peace deal, Trump says

January 22, 2026

Russian President Vladimir Putin claimed Ukraine’s losses are eight times higher than those of Russia during an interview with Chinese media. Ludovic Marin | Afp | Getty Images An “abnormal hatred” between Russia and Ukraine’s leaders remains a barrier to ending the war, but a peace deal is getting closer, President Donald Trump said as […]

World

Denmark open to ‘Golden Dome’ talks after Trump touts framework Greenland deal

January 22, 2026

Prime Minister Mette Frederiksen holds a press conference in the Mirror Hall at the Prime Minister’s Office, at Christiansborg in Copenhagen, Denmark, on January 13, 2026. Nurphoto | Nurphoto | Getty Images Danish Prime Minister Mette Frederiksen on Thursday welcomed U.S. President Donald Trump’s Greenland pivot, saying the country is prepared to hold talks with […]

World

European markets set to rocket on Trump’s Greenland ‘deal,’ tariffs retreat

January 22, 2026

US President Donald Trump delivers a special address during the World Economic Forum (WEF) annual meeting in Davos on January 21, 2026. The World Economic Forum takes place in Davos from January 19 to January 23, 2026. Fabrice Coffrini | Afp | Getty Images LONDON — European stocks are expected to open higher Thursday after […]